Literature DB >> 7053309

Metoprolol withdrawal phenomena: mechanism and prevention.

R E Rangno, S Langlois, A Lutterodt.   

Abstract

Eight patients taking metoprolol (300 mg/day) for essential hypertension were studied after abrupt withdrawal and placebo replacement of the drug. A 52% average rebound increase in cardiac chronotropic sensitivity to isoproterenol and 15% rebound rise in resting heart rate occurred in all patients between 2 to 8 days after metoprolol withdrawal (P less than 0.05). Holter monitoring showed no associated arrhythmia. A transient increase in blood pressure occurred in one patient and withdrawal-like symptoms were noted in three patients. There were no meaningful changes in plasma norepinephrine, epinephrine, thyroxine, or triiodothyronine. Seven of the eight patients were again studied serially after the same metoprolol dosing, during a prolonged low-dose withdrawal schedule (50 mg/day for 10 days) and during placebo. Prolonged low dose before complete metoprolol withdrawal decreased but did not completely prevent the changes observed after abrupt withdrawal. The observed rebound of cardiac beta-adrenergic sensitivity may have application to the mechanism and prevention of the beta-blocker syndrome in patients with angina.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053309     DOI: 10.1038/clpt.1982.2

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

1.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 2.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

Review 3.  Central nervous system mechanisms in blood pressure control.

Authors:  A D Struthers; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Medication management on sick days.

Authors:  Tom N Lea-Henry; Jonathan Baird-Gunning; Elizabeth Petzel; Darren M Roberts
Journal:  Aust Prescr       Date:  2017-10-03

5.  Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study.

Authors:  Donald Redelmeier; Damon Scales; Alexander Kopp
Journal:  BMJ       Date:  2005-10-06

6.  A comparison of a combination of penbutolol and frusemide with the two compounds individually in the treatment of hypertension.

Authors:  D R Chadha; J J Houtzagers
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

7.  Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.

Authors:  Y Giudicelli; D Lacasa; B Agli; A Leneveu
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.

Authors:  R E Rangno; S Langlois
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment.

Authors:  P R Walker; A J Marshall; S Farr; B Bauminger; G Walters; D W Barritt
Journal:  Br Heart J       Date:  1985-03

10.  Unchanged peripheral sympathetic activity following withdrawal of chronic metoprolol treatment. A study of noradrenaline concentrations and kinetics in plasma.

Authors:  G Olsson; M Daleskog; P Hjemdahl; N Rehnqvist
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.